Page last updated: 2024-11-05

cobalt sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cobalt sulfate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cobalt(2+) sulfate : A compound of cobalt and sulfate in which the ratio of cobalt (+2 oxidation state) to sulfate is 1:1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24965
CHEBI ID53470
MeSH IDM0086545

Synonyms (41)

Synonym
sulfuric acid, cobalt(2+) salt (1:1)
cobalt(ii) sulfate (1:1)
cobalt sulphate
cobalt sulfate (1:1)
cobalt(2+) sulfate
cobalt monosulfate
cobalt(ii) sulphate
cobaltous sulfate salt (1:1)
cobaltous sulfate
cobalt sulfate (coso4)
cobalt (2+) sulfate
cobalt brown
cobalt sulfate
hsdb 240
einecs 233-334-2
cobalt(ii) sulfate
10124-43-3
C17383
CHEBI:53470 ,
coso4
A800357
h7965x29hx ,
unii-h7965x29hx
ec 233-334-2
cobaltous sulphate
cobaltous sulfate [mi]
cobalt sulfate [who-dd]
cobaltous sulfate [hsdb]
cobalt sulphate (1:1)
cobalt(2+) sulphate
AKOS015903535
cobalt (ii) sulfate
KTVIXTQDYHMGHF-UHFFFAOYSA-L
DTXSID1031042
cobalt( cento) sulfate hydrate
Q411214
cobalt(2+);sulfate
139939-65-4
mfcd00010943
cobalt(ii) sulfate, anhydrous
cobalt(+2) cation sulfate

Research Excerpts

Overview

Cobalt sulfate is a water-soluble cobalt salt with a variety of industrial and agricultural uses.

ExcerptReferenceRelevance
"Cobalt sulfate is a water-soluble cobalt salt with a variety of industrial and agricultural uses. "( Inhalation toxicity and carcinogenicity studies of cobalt sulfate.
Bucher, JR; Chou, BJ; Grumbein, SL; Hailey, JR; Haseman, JK; Mellick, PW; Roycroft, JR; Sills, RC, 1999
)
2

Toxicity

ExcerptReferenceRelevance
" The values obtained for the LD50 (7 days) were 133, 194, 198 and 279 mg of Co/kg respectively, when the salts were given orally."( [Acute toxicity and hematological and serum changes caused by various cobalt salts in rats].
Domingo, JL; Llobet, JM, 1983
)
0.27
" The high concentration of cobalt nanoparticles required for cytotoxicity of macrophages in vitro suggests that increased production of cobalt nanoparticles in vivo, due to excessive MoM implant wear, may lead to local adverse biological effects."( Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages in vitro.
Beard, D; Gill, HS; Glyn-Jones, S; Kwon, YM; Murray, DW; Xia, Z, 2009
)
0.35
" In vitro bioelution in simulated gastric fluid was the most precise predictor of the difference in the oral RDT lowest observed adverse effect levels of 2 compounds representing the highly and poorly bioaccessible subset of substances."( Bioelution, Bioavailability, and Toxicity of Cobalt Compounds Correlate.
Burzlaff, A; Danzeisen, R; Dourson, M; Verberckmoes, S; Viegas, V; Williams, DL, 2020
)
0.56

Compound-Compound Interactions

ExcerptReferenceRelevance
"The effects of supplementing lambs with Co, either alone or in combination with vitamin B and Se, were evaluated over the period from weaning to selection for slaughter."( Cobalt supplementation, alone or in combination with vitamin B and selenium: Effects on lamb performance and mineral status.
Fagan, SP; Hanrahan, JP; Keady, TW, 2017
)
0.46

Bioavailability

ExcerptReferenceRelevance
" Due to the lack of toxicity and carcinogenicity data following exposure to cobalt, and questions regarding bioavailability following exposure to different forms of cobalt, the NTP conducted two chronic inhalation exposure studies in rats and mice, one on soluble cobalt sulfate heptahydrate, and a more recent study on insoluble cobalt metal."( Comparative toxicity and carcinogenicity of soluble and insoluble cobalt compounds.
Baker, GL; Behl, M; Bucher, JR; Dill, JA; Hayden, BK; Herbert, RA; Hooth, MJ; Roycroft, JH; Stout, MD, 2015
)
0.6
" We were able to show a good correlation between high in vitro bioaccessibility with high in vivo bioavailability and subsequent high in vivo toxicity; consequently, low in vitro bioaccessibility correlated well with low in vivo bioavailability and low in vivo toxicity."( Bioelution, Bioavailability, and Toxicity of Cobalt Compounds Correlate.
Burzlaff, A; Danzeisen, R; Dourson, M; Verberckmoes, S; Viegas, V; Williams, DL, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
metal sulfateSulfate salts where the cation is a metal ion.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (57)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (24.56)18.7374
1990's11 (19.30)18.2507
2000's14 (24.56)29.6817
2010's16 (28.07)24.3611
2020's2 (3.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 73.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index73.77 (24.57)
Research Supply Index4.20 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index124.90 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (73.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.54%)5.53%
Reviews1 (1.54%)6.00%
Case Studies1 (1.54%)4.05%
Observational0 (0.00%)0.25%
Other62 (95.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]